Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

4 Stocks To Watch Today: ABUS, EXAS, MTCH, SGMO

Published 10/03/2017, 11:56 PM
Updated 07/09/2023, 06:31 AM

Arbutus Biopharma Corp (NASDAQ:ABUS), which I spotted a week and a half ago when it exploded, pulled back in a nice flag and reversed on Monday. As you can see, it made a nominal new high at 8.25, and pulled back and closed up 30 cents, or 4%, to 7.55, on 1.4 million shares traded. At this point, it may need to back and fill. With 3 1/2 days to cover , it might make a quick move to the 10-11 range.

EXACT Sciences Corporation (NASDAQ:EXAS) had a really nice day on Tuesday, jumping 1.18, or 2.5%, to 49.12, on 3 million shares traded, and reached over 50.00 for the first time. The long-term up-channel indicates there could be more upside. I wouldn’t be surprised if the mid-channel angle gets it up to 55, and 70 eventually.

Match Group, Inc. (NASDAQ:MTCH) exploded out of a rising wedge on Tuesday, popping 85 cents, or 4%, to 24.75. on 2.7 million shares traded, making it all the way up to 25.25. The way the wedge is constructed and looking right now, it could very well move into the high 20’s, maybe even the low 30’s. It has 9.3 days to cover .

Sangamo Therapeutics Inc (NASDAQ:SGMO) is doing great, running up for five days in a row, and on Tuesday it popped another 55 cents, or 3.4%, to 16.75, on 2.1 million shares traded. It sure looks like it’s headed to 20.

On the long side, stocks included Arbutus Biopharma Corporation (ABUS), Celsion Corporation (CLSN), Endocyte Inc (NASDAQ:ECYT), Editas Medicine Inc. (EDIT), Endologix, Inc. (ELGX), Exact Sciences Corporation (EXAS), Helios and Helios and Matheson Analytics Inc (NASDAQ:HMNY), Intelsat S.A. (I), Iteris, Inc. (ITI), Kopin Corporation (NASDAQ:KOPN), MannKind Corporation (MNKD), Marinus Pharmaceuticals, Inc. (MRNS), Medical Transcription Billing Corp. (MTBC), Match Group, Inc. (MTCH), Intellia Therapeutics Inc. (NTLA), Pixelworks, Inc. (PXLW), Quotient Technology Inc. (QUOT), sgh, Sangamo Therapeutics, Inc. (SGMO), Varonis Systems, Inc. (VRNS), Yirendai Ltd. (NYSE:YRD), and Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE).

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

SGMO -it sure looks like it's headed to 10!
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.